JUL 31, 2018 8:01 PM PDT

Two Molecules Identified For Treating Traumatic Brain Injury (TBI)

WRITTEN BY: Nouran Amin

Scientists at Rutgers University have discovered two molecules that protect nerve cells, serving as motivation to develop new drugs for brain damage. The discovery comes after 10 years of dedicated research on traumatic brain injury (TBI). The molecules were seen to promote full recovery after TBI in mouse models according to results published in the Neurobiology of Disease.

TBI, considered a major cause of disability, occurs when a sudden, violent blow or jolt, to the head leading to brain damage. According to the Centers for Disease Control and Prevention (CDC) TBI is defined as "a disruption in the normal function of the brain that can be caused by a bump, blow, or jolt to the head, or penetrating head injury." When the brain collides with the insides of the skull, a bruising of the brain or tearing/bleeding of the nerves fibers may occur. Additionally, when the skull fractures, a piece of the skull resulting from the injury can penetrate the brain tissue. TBI can be caused by a variety of events, commonly falls, sports injuries, gunshot wounds, physical aggression, and road traffic accidents. Symptoms of TBI widely depend on the severity of the accident, the extent of the damage, and which parts of the brain are affected. In some mild cases, confusion and headaches occur. However, serious cases can result in unconsciousness, amnesia, disability, coma, and death or long-term impairment. For treatment options, all approaches are geared towards trying to prevent neurons (nerve cells) from degeneration or prompting neuron survival. This is because TBI alters neural circuits within damaged brain regions.

"The big issue with treatment after TBI is that there are no drugs that work well on patients to restore memory, and we're targeting re-connectivity of neural circuitry," explains Bonnie L. Firestein, the senior author of the research study and a professor in the Department of Cell Biology and Neuroscience at Rutgers University-New Brunswick. "That means we want our neurons to function properly and connect with other neurons. We want to allow people to retain their cognition and ability to remember and learn, so our angle is novel."

Specifically, investigators discovered a protein by the name of cypin, an enzyme that degenerates guanine; an important building block for DNA and RNA molecules in cells. The researcher’s previously proved that cypin was involved in promoting the proper shape in neurons and "keeping them happy," says Firestein. The research discovered that speeding the breakdown of guanine protects the neurons from damage as well as retaining brain function.

Using research in this study, scientists from Rutgers-New Brunswick, University of Pennsylvania, Fox Chase Chemical Diversity Center Inc. and Columbia University want to continue advancing on to the discoveries made into this study to develop drugs for patients of TBI.

Source: Neurobiology of Disease

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 30, 2020
Cancer
Chemokines Could be the Key in Controlling Glioma Stem Cells
SEP 30, 2020
Chemokines Could be the Key in Controlling Glioma Stem Cells
The transformation of a healthy cell into a cancerous one often comes with a slew of cellular signaling changes.  T ...
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
NOV 02, 2020
Drug Discovery & Development
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
NOV 02, 2020
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
Researchers from the Medical Univesity of Vienna in Austria have found that a peptide (a small protein molecule) found i ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
NOV 18, 2020
Technology
Using Machine Learning to Build Chemical Libraries
NOV 18, 2020
Using Machine Learning to Build Chemical Libraries
Using machine learning in drug discovery is no longer a novel procedure and has been well documented in recent literatur ...
Loading Comments...